REVIEW
|
doi:10.20944/preprints202404.0944.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Immune checkpoint inhibitor; ipilimumab; pembrolizumab
Online: 16 April 2024 (03:30:17 CEST)